Pancreatic
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Open Label Study to Assess Efficacy and Safety of Olaparib in Confirmed Genetic BRCA1 or BRCA2 Mutation Pats (NCT01078662) | AstraZeneca | 2010-02-21 |
Track Pancreatic automatically
Every clearance here is in the API, with alerts when new ones post.